CD4/CD8 double-positive, acute type of adult T-cell leukemia/lymphoma with extensive cutaneous involvement

2006 ◽  
Vol 45 (10) ◽  
pp. 1193-1195 ◽  
Author(s):  
Yong Ju Kim ◽  
Eul Sang Hwang ◽  
Il-Hwan Kim ◽  
Dong Soo Yu
2020 ◽  
Vol 59 (8) ◽  
Author(s):  
Akiko Arimura ◽  
Kazuyasu Fujii ◽  
Youhei Uchida ◽  
Yuko Higashi ◽  
Naosuke Arima ◽  
...  

2020 ◽  
Vol 8 ◽  
pp. 232470962096684
Author(s):  
Toshihiko Matsuo ◽  
Takehiro Shimizu ◽  
Takehiro Tanaka ◽  
Akira Yamamoto ◽  
Hiroki Takasuka

This study reported 2 new patients and 16 historical cases with pathologically proven intraocular infiltration with adult T-cell leukemia and lymphoma (ATLL) to know the timing of intraocular infiltration in the disease course. The first case was a 67-year-old woman who developed bilateral vitreous opacity about half a year after the onset of acute type of ATLL that had been unresponsive to chemotherapy. She underwent vitrectomy combined with cataract surgery in both eyes. She had bilateral optic disc atrophy and localized retinal white infiltrates in both eyes. Cytological examination of vitreous aspirates demonstrated medium-sized cells with aberrant flower-like convoluted nuclei, positive for CD3, and thus indicative of T-cells. The second case was a 38-year-old man who was diagnosed acute type of ATLL at the presentation of acute kidney injury. About half a year after initial chemotherapy and allogeneic hematopoietic stem cell transplantation, he developed aqueous hypopyon in the right eye, concurrent with cutaneous and central nervous system relapse. Aqueous tap disclosed class V abnormal cells. The aqueous “pseudohypopyon” resolved in response to another round of chemotherapy with mogamulizumab. In review of 18 patients, intraocular infiltration with ATLL was diagnosed by vitrectomy in 9, aqueous tap in 3, chorioretinal biopsy in 3, and autopsy in 3. The intraocular infiltration developed concurrently with systemic diagnosis of ATLL in 5 patients, but developed later after chemotherapy in 13. In conclusion, intraocular infiltration with ATLL appears rare, and pathological diagnosis by vitrectomy and aqueous tap would help determine therapeutic plan in relapse after chemotherapy.


2008 ◽  
Vol 48 (1) ◽  
pp. 1-10 ◽  
Author(s):  
Jia Wang ◽  
Kazuhisa Hasui ◽  
Atae Utsunomiya ◽  
Xinshan Jia ◽  
Takami Matsuyama ◽  
...  

2015 ◽  
Vol 108 (10) ◽  
pp. 775-781
Author(s):  
Hiromi Nagano ◽  
Yumi Miyamoto ◽  
Tomohiro Jimura ◽  
Hiroyuki Iuchi ◽  
Yuichi Kurono

Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 845-845
Author(s):  
Noriaki Yoshida ◽  
Kennosuke Karube ◽  
Atae Utsunomiya ◽  
Kunihiro Tsukasaki ◽  
Yoshitaka Imaizumi ◽  
...  

Abstract Introduction Adult T-cell leukemia/lymphoma (ATL) is a human T-cell leukemia virus type-1-induced neoplasm with four clinical subtypes; acute, lymphoma, chronic and smoldering. Although chronic and smoldering subtypes are regarded as indolent ATL, about half of these cases progress to acute type ATL and subsequent death. Therefore, cases of indolent ATL also have poor prognosis and acute transformation is a predictive indicator for patients with indolent ATL. However, the molecular pathogenesis of acute transformation remains unknown. In the present study, oligo-array comparative genomic hybridization (CGH) and comprehensive gene-expression profiling (GEP) were applied to 27 and 35 cases of chronic and acute type ATL, respectively, in an effort to delineate the molecular pathogeneses of ATL, and especially the molecular mechanism of acute transformation. Materials and Methods All DNA and RNA used in this study were extracted from purified CD4-positive cells. Oligo-array CGH analyses and comprehensive GEP analyses were performed on 27 and 35 cases of chronic and acute type ATL, respectively. Subsequently, we established Tet-OFF ATL cell lines for functional analyses. Results Oligo-array CGH revealed that genomic loss of 9p21.3 was significantly characteristic of acute type ATL, but not chronic type ATL (p-value= 0.039). Although the minimal common deleted region of 9p21.3 contained MTAP, CDKN2A and CDKN2B, the expression level of only CDKN2A was reduced with genomic loss of 9p21.3 (Figure 1). Moreover, analysis of serial samples of a chronic type ATL patient showing acute transformation also revealed that reduction of CDKN2A expression by 9p21.3 loss was associated with acute transformation in this case. CDKN2A contains two known variants, INK4a and ARF. Re-expression of INK4a and ARF suppressed proliferation of Tet-OFF ATL cell lines, while the suppression efficiency of INK4a was stronger than that of ARF (Figure 2). In cell-cycle assays, the induction of INK4a and ARF decreased the proportion of S-phase cells. Additionally, re-expression of INK4a also increased the amount of apoptotic cells in induced cell lines, while re-expression of ARF did not have this effect. Since CDKN2A is a well-known cell cycle regulator, deregulation of the cell-cycle might be involved in acute transformation of chronic type ATL. In fact, deregulation of the cell-cycle pathway has been reported as a predictive indicator for the outcome in diffuse large B-cell lymphoma patients (Cancer Cell, 22:359-372). Therefore, we examined whether chronic ATL patients had alterations in cell-cycle related genes and found that chronic ATL patients could be divided into two groups. The group possessing alterations in these genes (referred to as “Cell cycle Alteration”) showed poorer prognosis compared with the group lacking such alterations (referred to as “Clean”) (p-value= 0.037) (Figure 3). Additionally, patients with such alterations tended to have earlier progression to acute type ATL. Conclusion These findings indicated that cell cycle-related genes play an important role in acute transformation and should serve as good prognostic markers for chronic type ATL. Disclosures: No relevant conflicts of interest to declare.


2000 ◽  
Vol 39 (1-2) ◽  
pp. 217-222 ◽  
Author(s):  
Yayoi Takezako ◽  
Yoshinobu Kanda ◽  
Chiaki Arai ◽  
Naoki Takezako ◽  
Yuko Shirai ◽  
...  

1995 ◽  
Vol 34 (11) ◽  
pp. 1130-1133 ◽  
Author(s):  
Yoshitaka FURUKAWA ◽  
Toshihide OKADOME ◽  
Mitsutoshi TARA ◽  
Kiyoshige NIINA ◽  
Shuji IZUMO ◽  
...  

2006 ◽  
Vol 68 (2) ◽  
pp. 162-166
Author(s):  
Kotaro ITO ◽  
Yumiko KUBOTA ◽  
Minao FURUMURA ◽  
Juichiro NAKAYAMA

Sign in / Sign up

Export Citation Format

Share Document